2008Journal of Henan University of Science & TechnologyRequires access

Expression of Osteopontin in Breast Carcinoma

Xing Lu-qi

Open publisher page 0 citations

Abstract

Objective To explore the expression of OPN and its significance in breast carcinoma. Methods SP immunohistochemical method was used to examine the expression of OPN in 86 cases of breast carcinoma and analyze its relationship with clinical pathological characteristics and survival rate of 5 years. Results The positive rates of OPN was 53.5%(46/86).It was 38.1%,47.3%,74.7% in carcinomas with gradeⅠ,Ⅱand Ⅲ respectively,72.2% and 40.0% in lymph nodes metastases positive group and negative group,38.9% and 78.1% among patients who survived more than 5 years and less than 5 years respectively;The expression of OPN had negative relationship with survival of rate 5 years(P0.05).Cox model revealed that lymph nodes metastases and grade of histology were independent prognostic factors in breast carcinoma. Conclusion OPN is highly expressed in breast carcinoma,and positively correlated to grade of histology and lymph nodes metastases,and negatively correlated to survival rate of 5 years.OPN is not an independent prognostic factor in breast carcinoma.

About this research paper

What this paper is about

Objective To explore the expression of OPN and its significance in breast carcinoma. Methods SP immunohistochemical method was used to examine the expression of OPN in 86 cases of breast carcinoma and analyze its relationship with clinical pathological characteristics and survival rate of 5 years. Results The positive rates of OPN was 53.5%(46/86).It was 38.1%,47.3%,74.7% in carcinomas with gradeⅠ,Ⅱand Ⅲ respectively,72.2% and 40.0% in lymph nodes metastases positive group and negative group,38.9% and 78.1% among patients who survived more than 5 years and less than 5 years respectively;The expression of OPN had negative relationship with survival of rate 5 years(P0.05).Cox model revealed that lymph nodes metastases and grade of histology were independent prognostic factors in breast carcinoma. Conclusion OPN is highly expressed in breast carcinoma,and positively correlated to grade of histology and lymph nodes metastases,and negatively correlated to survival rate of 5 years.OPN is not an independent prognostic factor in breast carcinoma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the expression of OPN and its significance in breast carcinoma. Methods SP immunohistochemical method was used to examine the expression of OPN in 86 cases of breast carcinoma and analyze its relationship with clinical pathological characteristics and survival rate of 5 years. Results The positive rates of OPN was 53.5%(46/86).It was 38.1%,47.3%,74.7% in carcinomas with gradeⅠ,Ⅱand Ⅲ respectively,72.2% and 40.0% in lymph nodes metastases positive group and negative group,38.9% and 78.1% among patients who survived more than 5 years and less than 5 years respectively;The expression of OPN had negative relationship with survival of rate 5 years(P0.05).Cox model revealed that lymph nodes metastases and grade of histology were independent prognostic factors in breast carcinoma. Conclusion OPN is highly expressed in breast carcinoma,and positively correlated to grade of histology and lymph nodes metastases,and negatively correlated to survival rate of 5 years.OPN is not an independent prognostic factor in breast carcinoma.

Key concepts: Osteopontin, Breast carcinoma, Medicine, Histology, Pathological, Immunohistochemistry, Lymph, Carcinoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of Osteopontin in Breast Carcinoma — Research Paper | ScholarLens